Ahmadreza Jodati

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Coronary Artery Bypass Grafting

Endoplasmic Reticulum Stress

Anti Inflammatory

Top Venues

Clinical and experimental pharmacology & physiology

Hormone molecular biology and clinical investigation

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Yousef Faridvand, Hamid Kazemzadeh, Vahid Vahedian, Pourya Mirzajanzadeh, Hamid Reza Nejabati, Nasser Safaie, Nazila Fathi Maroufi, Masoud Pezeshkian, Mohammad Nouri, Ahmadreza Jodati
Dapagliflozin attenuates high glucose-induced endothelial cell apoptosis and inflammation through AMPK/SIRT1 activation. Clinical and experimental pharmacology & physiology 49 (6) (2022)
Saeideh Akseh, Mohammad-Ali Karimi, Nasser Safaie, Amir Valizadeh, Dara Rahmanpour, Masoud Pezeshkian, Mohammad Nouri, Yousef Faridvand, Ahmadreza Jodati
The serum levels of testosterone in coronary artery disease patients; relation to NO, eNOS, endothelin-1, and disease severity. Hormone molecular biology and clinical investigation (2021)
Yousef Faridvand, Parinaz Haddadi, Hamid Reza Nejabati, Samad Ghaffari, Elham Zamani-Gharehchamani, Samira Nozari, Mohammad Nouri, Ahmadreza Jodati
Sulforaphane modulates CX3CL1/CX3CR1 axis and inflammation in palmitic acid-induced cell injury in C2C12 skeletal muscle cells. Molecular biology reports 47 (10) (2020)